Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Perspective Therapeutics, Inc. | 600,000 | reported | 04 Sept 2025 | tx 1+600,000 |
| Spero Therapeutics, Inc. | 65,000 | reported | 02 Jan 2019 | tx 8+109,976−65,880 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Sept 2025 | GRANT_AWARD | Perspective Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Spero Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 05 Jul 2018 | EXERCISE | Spero Therapeutics, Inc. | 2,000 | 5.90 USD | |
| 05 Jul 2018 | SALE | Spero Therapeutics, Inc. | 2,000 | 17.50 USD | |
| 05 Jul 2018 | EXERCISE | Spero Therapeutics, Inc. | 2,000 | 0.00 USD | deriv |
| 13 Dec 2017 | GRANT_AWARD | Spero Therapeutics, Inc. | 27,795 | 0.00 USD | deriv |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 10,181 | — | |
| 06 Nov 2017 | PURCHASE | Spero Therapeutics, Inc. | 5,000 | 14.00 USD | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 61,880 | 0.00 USD | deriv |